It is worrying that the Tendulkar method, chosen by the Planning Commission to calculate the poverty line in its latest figures, underestimates the levels of poverty while overestimating poverty reduction. The figures show that 29.8% or 360 million Indians were poor in 2009-10 as compared to 37.2% or 400 million in 2004-05. A poor person has been defined as one who spends R28 per day in urban areas and R22.5...

The great poverty debate has been re-ignited, pitting liberal, pro-market economists against left-of-centre economists of the JNU genre. Is the Tendulkar Committee's poverty line - expenditure of 32 a day in urban areas and 26 in rural areas -an affront to the poor, an estimate that could only have been made by a committee whose members had never known a day's poverty themselves? Or is it a realistic estimate of what...

According to data released Monday by India’s Planning Commission, the number of people living in absolute poverty in India decreased by 12.5% between 2004-2005 and 2009-2010. India’s official poverty rate stands at 29.8%, or close to 350 million people using 2010 population figures, down from around 37.2% or 400 million previously. The announcement was based on an analysis of data gathered from roughly 100,000 households between July 2009 and June 2010,...

An opportunity has been forsaken to strengthen our economic fundamentals while improving the lives of the people, increasing the divide between India Shining and India Suffering. While the people were hoping for relief in the current budget, the Finance Minister was faced with the task of reversing the slowing growth rate and raging inflation. He had a choice in this budget. He, however, chose a path that is going to worsen...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...